Efficacy and Safety of Acupuncture Combined with Herbal Medicine in Treating Gouty Arthritis: Meta-Analysis of Randomized Controlled Trials
Liang et al. · Evidence-Based Complementary and Alternative Medicine · 2021
Evidence Level
MODERATEOBJECTIVE
To evaluate the efficacy and safety of acupuncture combined with Chinese herbal medicine in the treatment of gouty arthritis
WHO
1,065 patients with gouty arthritis (729 men, 336 women, 18-80 years)
DURATION
5 to 21 days of treatment
POINTS
Yinlingquan 阴陵泉 (SP-9), Zusanli 足三里 (ST-36), Sanyinjiao 三阴交 (SP-6), Quchi 曲池 (LI-11), Taichong 太冲 (LR-3), local points
🔬 Study Design
Acupuncture + Herbal Medicine
n=540
Needle acupuncture or bloodletting + Chinese herbal medicine
Control
n=525
Conventional therapy, anti-inflammatory drugs, or monotherapies
📊 Results in numbers
Clinical efficacy vs conventional therapy
Uric acid reduction vs acupuncture
VAS improvement vs anti-inflammatory drugs
Adverse events
📊 Outcome Comparison
Clinical efficacy (%)
Adverse events (%)
This study showed that the combination of acupuncture and Chinese herbal medicine is more effective than conventional treatments for gouty arthritis. The combined treatment significantly reduced pain, swelling, and uric acid levels, with fewer side effects than anti-inflammatory drugs.
Article summary
Plain-language narrative summary
This meta-analysis was the first comprehensive evaluation of the efficacy of acupuncture combined with Chinese herbal medicine for gouty arthritis, including 14 randomized clinical trials with 1,065 participants. Gouty arthritis is a painful inflammatory condition caused by the accumulation of uric acid crystals in the joints, traditionally treated with nonsteroidal anti-inflammatory drugs and corticosteroids, which can cause significant adverse effects with prolonged use. The researchers conducted a systematic search of multiple databases, including PubMed, Cochrane Library, EMBASE, and Chinese databases, through March 2021. Only randomized clinical trials comparing acupuncture combined with Chinese herbal medicine versus conventional therapies, acupuncture alone, herbal medicine alone, or anti-inflammatory drugs were included.
The methodology strictly followed PRISMA guidelines for systematic reviews. The experimental intervention consisted of acupuncture (including electroacupuncture, three-edged needle bloodletting, and auricular acupuncture) combined with Chinese herbal medicine (traditional formulas and Chinese patent medicines). The most frequently used acupuncture points included Yinlingquan 阴陵泉 (SP-9), Zusanli 足三里 (ST-36), Sanyinjiao 三阴交 (SP-6), Quchi 曲池 (LI-11), and Taichong 太冲 (LR-3), often combined with local pain points (ashi points). Treatments lasted between 5 and 21 days, with daily or alternate-day sessions.
The results demonstrated consistent superiority of the combined therapy. Compared with conventional therapy, the combined treatment showed 11% higher clinical efficacy (RR 1.11, 95% CI 1.06-1.15, p < 0.00001). Compared with acupuncture alone, efficacy was 22% higher (RR 1.22, 95% CI 1.06-1.41, p = 0.007), and versus herbal medicine alone, 31% higher (RR 1.31, 95% CI 1.08-1.57, p = 0.005). The reduction in uric acid levels was significantly greater with combined therapy (-85.63 μmol/L, 95% CI -102.89 to -68.37, p < 0.00001) compared with acupuncture alone.
Improvement on the visual analog pain scale was also greater (-0.78 points, 95% CI -1.12 to -0.45, p < 0.00001) versus anti-inflammatory drugs. Crucially, the incidence of adverse events was significantly lower in the combined therapy group (OR 0.16, 95% CI 0.08-0.32, p < 0.00001). Reported adverse events were primarily gastrointestinal reactions in the control groups, while the experimental group exhibited mainly mild discomfort related to needle insertion. The clinical implications are substantial, suggesting that integrating acupuncture with Chinese herbal medicine offers an effective and safe therapeutic alternative for patients with gouty arthritis, particularly those who experience significant adverse effects with conventional medications.
The approach demonstrated benefits in both clinical and laboratory parameters, including reduced pain, local inflammation, and serum uric acid levels.
Strengths
- 1First comprehensive meta-analysis on the topic
- 2Rigorous methodology following PRISMA guidelines
- 3Substantial sample of 1,065 participants
- 4Analysis of multiple clinical and laboratory outcomes
- 5Demonstrated low incidence of adverse events
Limitations
- 1Majority of studies published in Chinese
- 2Unclear risk of bias in several studies
- 3Moderate heterogeneity between studies
- 4Limited follow-up duration
- 5Absence of blinding in most studies
Expert Commentary
Dr. Marcus Yu Bin Pai
MD, PhD · Pain Medicine · Physical Medicine and Rehabilitation · Medical Acupuncture
▸ Clinical Relevance
Gouty arthritis represents a recurrent therapeutic challenge in rheumatology and physiatry services, especially when the patient accumulates renal, cardiovascular, or gastrointestinal comorbidities that limit prolonged use of NSAIDs and colchicine. This meta-analysis, gathering 1,065 participants across 14 randomized trials, offers the first robust quantitative synthesis for the combination of acupuncture with Chinese herbal medicine in this setting. The 11% gain in overall clinical efficacy compared with conventional therapy, associated with an 85.63 μmol/L reduction in serum uric acid levels and a 0.78-point reduction on the VAS compared with anti-inflammatory drugs, translates into clinically tangible benefit. The safety profile — an OR of 0.16 for adverse events — reinforces the feasibility of this approach in patients who tolerate standard pharmacological regimens poorly, positioning the combined therapy as a real adjuvant — not merely a complement — to conventional gout management.
▸ Notable Findings
The most striking finding is not merely the superiority over conventional therapy but the magnitude of the synergistic effect within the very spectrum of Traditional Chinese Medicine: the combination outperforms acupuncture alone by 22% and herbal medicine alone by 31% in overall clinical efficacy. This suggests that the mechanisms of action complement each other in a non-additive way, likely because acupuncture acts predominantly through local neuroinflammatory modulation and autonomic axes, while herbal compounds interfere with urate metabolic pathways — orthogonal mechanisms that, when combined, achieve outcomes neither would achieve alone. The marked reduction in serum uric acid levels adds a dimension beyond symptomatic relief, pointing to potential impact on the prevention of recurrent flares. The points used — Yinlingquan 阴陵泉, Zusanli 足三里, Sanyinjiao 三阴交 — have neurophysiological support in studies of modulation of the systemic inflammatory response, lending mechanistic coherence to the results.
▸ From My Experience
In my rehabilitation and pain practice, I have managed patients with gout referred primarily after gastrointestinal intolerance to NSAIDs or contraindication to colchicine due to moderate renal insufficiency — exactly the profile where this study adds the most decisional value. I usually introduce acupuncture in the subacute phase of the flare, once inflammation is past its peak and local needling is tolerable; in the intensely acute phase, I prefer to wait 48 to 72 hours before initiating. In general I observe a perceptible reduction in pain between the second and fourth sessions, with daily protocols during the first five to seven days, transitioning to alternate-day sessions thereafter. Combination with strict dietary guidance and hydration enhances the response in a way any isolated intervention rarely achieves. I do not recommend the approach in patients with extensive articular tophi or advanced gouty nephropathy without parallel pharmacological uricosuric management — acupuncture, in that scenario, does not replace allopurinol or febuxostat. The safety data in this work confirm what I see routinely: the relevant adverse events concentrate in the groups using NSAIDs, not in those receiving acupuncture.
Full original article
Read the full scientific study
Evidence-Based Complementary and Alternative Medicine · 2021
DOI: 10.1155/2021/8161731
Access original articleScientific Review

Marcus Yu Bin Pai, MD, PhD
CRM-SP: 158074 | RQE: 65523 · 65524 · 655241
PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture. Scientific review and curation of every entry in this library.
Learn more about the author →Medical disclaimer: This content is for educational purposes only and does not replace consultation, diagnosis, or treatment by a qualified professional. Some information may be assisted by artificial intelligence and is subject to inaccuracies. Always consult a physician.
Content reviewed by the medical team at CEIMEC — Integrated Centre for Chinese Medicine Studies, a reference in Medical Acupuncture for over 30 years.
Related articles
Based on this article’s categories